CLSI H30

Procedure for the Determination of Fibrinogen in Plasma, 2nd Edition

This document provides general guidelines for performing the fibrinogen assay in the clinical laboratory. It also includes reporting of results and in vivo and in vitro conditions that may alter results. (See related publication H21-A3 in this section.)

This document is available in electronic format only.

More Details

Member price:

List Price:

PDF Add to Cart

Details

Chairholder: Charles F. Arkin, MD

Date of Publication: November 1, 2001

Order Code PDF: CLSI H30A2E
ISBN Number: 1-56238-439-2

Order Code Print: print not available

Edition: Second

Pages: 16

CLSI H30 Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.

CLSI H30 Abstract

Clinical and Laboratory Standards Institute document H30-A2—Procedure for the Determination of Fibrinogen in Plasma; Approved Guideline—Second Edition is a performance guideline for laboratory and/or clinical healthcare professionals responsible for the routine performance of fibrinogen assays. This guideline describes a technique, based on the method described by Clauss,1 that is practical, precise, and widely used in the clinical laboratory. Preanalytical and analytical factors and conditions that may alter results are discussed.